Too many children die each year from difficult-to-treat cancers. The rarity of specific cancers, high cost of drug testing, and limited access to trials have impeded the development of cures. Today, the plunging cost of genome sequencing, combined with new initiatives to pool genomics data, the application of big-data analytic methods and global collaboration between researchers and physicians promises a profound revolution in the treatment of childhood – and many other – cancers.

This panel discussion will be of interest to students, researchers, patients, and investors in the fields of big-data analytics, genomics, precision medicine, and anyone with an interest in science and technology.

Watch the discussion: